Susan Cohn, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 776 Asbury St, New Milford, NJ 07646 Phone: 800-950-6066 |
Denise Ort, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 358 Floral Ct, New Milford, NJ 07646 Phone: 201-836-6093 |
Ms. Donna L. Corcoran Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 142 Seminole Ave, New Milford, NJ 07646 Phone: 201-385-7190 Fax: 201-385-7190 |
Ms. Denise Corcoran Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 142 Seminole Ave, New Milford, NJ 07646 Phone: 201-385-7190 Fax: 201-385-7190 |
News Archive
The immune response to the bacterium that causes tuberculosis (TB) varies between patients of different ethnic origin, raising important implications for the development of tests to diagnose and monitor treatment for the disease, according to new research published today in the journal PLOS Pathogens.
A University of Alabama researcher is embarking on a $5.6 million phase-three, randomized, controlled clinical trial to evaluate the effectiveness of an innovative treatment that uses a noise-generating device, along with counseling, to alleviate the debilitating effects of tinnitus - that ringing in the ears that drives some people to distraction.
Chemists at the California Institute of Technology (Caltech) and The Scripps Research Institute (SRI) have developed an innovative technique to create cheap but highly stable chemicals that have the potential to take the place of the antibodies used in many standard medical diagnostic tests. James R. Heath, Ph.D., principal investigator of the Nanosystems Biology Cancer Center at Caltech, one of eight Centers of Cancer Nanotechnology Excellence, and K. Barry Sharpless, Ph.D., SRI, and their colleagues describe the new technique in the journal Angewandte Chemie International Edition.
Researchers are invited to contribute their abstracts to the World Congress on Osteoporosis 2010 (IOF WCO - ECCEO10), the largest global meeting devoted to all aspects of osteoporosis and osteoarthritis research and patient care. The Congress will be held in Florence, Italy from May 5-8, 2010.
› Verified 8 days ago